McKinley Carter Wealth Services’s Gilead Sciences GILD Stock Holding History

McKinley Carter Wealth Services’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$432K	Hold	3,100	–	–	0.02%	230
2025 Q4	$380K	Hold	3,100	–	–	0.02%	249
2025 Q3	$344K	Sell	3,100 -27	-0.9%	-$3.07K	0.02%	260
2025 Q2	$347K	Hold	3,127	–	–	0.02%	251
2025 Q1	$350K	Sell	3,127 -11	-0.4%	-$1.14K	0.02%	246
2024 Q4	$290K	Buy	3,138 +11	+0.4%	+$990	0.02%	248
2024 Q3	$262K	Sell	3,127 -7	-0.2%	-$534	0.02%	269
2024 Q2	$215K	Buy	3,134 +7	+0.2%	+$467	0.01%	289
2024 Q1	$229K	Hold	3,127	–	–	0.02%	280
2023 Q4	$253K	Hold	3,127	–	–	0.02%	269
2023 Q3	$234K	Sell	3,127 -526	-14%	-$40.5K	0.02%	270
2023 Q2	$282K	Hold	3,653	–	–	0.02%	252
2023 Q1	$303K	Buy	3,653 +526	+17%	+$43.6K	0.02%	248
2022 Q4	$268K	Buy	+3,127	New	+$248K	0.02%	254
2022 Q1	–	Sell	-3,517	Closed	-$255K	–	294
2021 Q4	$255K	Sell	3,517 -250	-7%	-$17.2K	0.02%	260
2021 Q3	$263K	Sell	3,767 -1,232	-25%	-$86.6K	0.02%	253
2021 Q2	$344K	Sell	4,999 -297	-6%	-$19.8K	0.03%	226
2021 Q1	$343K	Sell	5,296 -1,281	-19%	-$82.6K	0.03%	227
2020 Q4	$384K	Buy	6,577 +427	+7%	+$25.8K	0.05%	187
2020 Q3	$389K	Buy	6,150 +26	+0.4%	+$1.8K	0.09%	105
2020 Q2	$471K	Buy	6,124 +271	+5%	+$20.8K	0.12%	96
2020 Q1	$438K	Buy	5,853 +2,363	+68%	+$163K	0.13%	95
2019 Q4	$227K	Hold	3,490	–	–	0.05%	152
2019 Q3	$221K	Sell	3,490 -209	-6%	-$13.7K	0.06%	151
2019 Q2	$250K	Buy	3,699 +209	+6%	+$13.7K	0.07%	140
2019 Q1	$227K	Hold	3,490	–	–	0.06%	140
2018 Q4	$218K	Sell	3,490 -152	-4%	-$10.6K	0.07%	139
2018 Q3	$281K	Buy	3,642 +152	+4%	+$11.5K	0.08%	137
2018 Q2	$247K	Sell	3,490 -1,000	-22%	-$70.6K	0.08%	145
2018 Q1	$339K	Hold	4,490	–	–	0.11%	124
2017 Q4	$322K	Hold	4,490	–	–	0.11%	120
2017 Q3	$364K	Sell	4,490 -255	-5%	-$19.5K	0.14%	105
2017 Q2	$336K	Sell	4,745 -241	-5%	-$16K	0.15%	95
2017 Q1	$339K	Buy	4,986 +63	+1%	+$4.43K	0.16%	93
2016 Q4	$353K	Hold	4,923	–	–	0.18%	86
2016 Q3	$390K	Sell	4,923 -3,243	-40%	-$263K	0.2%	80
2016 Q2	$681K	Buy	8,166 +7	+0.1%	+$621	0.35%	61
2016 Q1	$750K	Sell	8,159 -210	-3%	-$18.9K	0.42%	63
2015 Q4	$847K	Buy	8,369 +63	+0.8%	+$6.55K	0.49%	55
2015 Q3	$816K	Sell	8,306 -843	-9%	-$93.6K	0.51%	53
2015 Q2	$1.07M	Buy	9,149 +1,438	+19%	+$157K	0.58%	53
2015 Q1	$757K	Buy	7,711 +2,732	+55%	+$277K	0.49%	57
2014 Q4	$469K	Buy	4,979 +275	+6%	+$28.4K	0.37%	59
2014 Q3	$501K	Buy	4,704 +80	+2%	+$7.83K	0.48%	51
2014 Q2	$383K	Sell	4,624 -154	-3%	-$12K	0.4%	52
2014 Q1	$339K	Sell	4,778 -432	-8%	-$33.9K	0.37%	63
2013 Q4	$391K	Sell	5,210 -174	-3%	-$12.1K	0.38%	70
2013 Q3	$338K	Buy	5,384 +417	+8%	+$24.9K	0.4%	56
2013 Q2	$255K	Buy	+4,967	New	+$259K	0.39%	53

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

McKinley Carter Wealth Services's GILD Position: Q1 2026 in Review

McKinley Carter Wealth Services held its Gilead Sciences (GILD) position steady in Q1 2026 at 3,100 shares worth $432K. The position accounts for 0.02% of the portfolio, ranked #230.

McKinley Carter Wealth Services first reported a position in GILD in Q2 2013 and has held it in 49 quarters since. The position peaked at $1.07M in Q2 2015. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

McKinley Carter Wealth Services held 3,100 shares of Gilead Sciences worth $432K as of Q1 2026.
McKinley Carter Wealth Services left its Gilead Sciences share count unchanged in Q1 2026.
Gilead Sciences made up 0.02% of McKinley Carter Wealth Services's portfolio in Q1 2026, its #230 holding.
McKinley Carter Wealth Services first reported a position in Gilead Sciences in Q2 2013 and has held it in 49 quarters since.
McKinley Carter Wealth Services's Gilead Sciences position peaked at $1.07M in Q2 2015.
2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on McKinley Carter Wealth Services's 13F filing for Q1 2026, filed 20 Apr 2026.